Former Neuralink co‑founder Max Hodak is making headlines again with his latest venture at the helm of Science Corp., where bold visions for the future of human cognition and medical technology are taking shape. What started as a brain‑computer interface company has evolved into something even more ambitious — a push toward technologies that could reshape how we understand and interact with the human brain and consciousness.
At Science Corp., Hodak is overseeing the development of Prima — a tiny retinal implant designed to restore vision for people with advanced macular degeneration. In clinical trials, the system helped many patients regain the ability to see and read again, a major milestone in neurotech and sensory restoration.
But the company’s aspirations go far beyond restoring sight. Hodak and his team are exploring advanced approaches like optogenetic gene therapy and even growing new neural tissue that could one day expand the limits of brain‑computer interfaces. Their long‑term thinking touches on some of the biggest questions in science, including the nature of consciousness itself.
In interviews, Hodak has hinted at a future where brain interfaces could not only help people with neurological conditions, but fundamentally change the way humans interact with technology — even blurring the lines between biological and artificial intelligence. While that future is still distant, the work happening now at Science Corp. offers a glimpse into how cutting‑edge neurotech might evolve.
Source: Read the original article from TechCrunch:
https://techcrunch.com/2025/12/05/after-neuralink-max-hodak-is-building-something-stranger/